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The differentiation pathway of natural killer  (NK): and killer  (K) cells is contro- 
versial. There is some evidence suggesting they are of T  cell lineage, whereas other 
data indicate that they are of monocyte/macrophage lineage (1,  2).  These previous 
studies demonstrated that T  cell or myeloid antigens were expressed on operationally 
defined NK and K cell populations, but no unique set of differentiation antigens were 
defined.  We  have  recently  identified  an  HNK-1  differentiation  antigen  that  is 
expressed on virtually all human granular lymphocytes with NK and K  cell function 
(3). These HNK-1 + cells in blood expand after birth as a function of age and sex (4). 
Two  distinct  phenotypes  of  HNK-1 +  cells  were  identified  that  might  represent 
different  stages in  NK cell  differentiation  (5).  Thus,  the  majority  (>60%)  of blood 
HNK-1 + cells expressed a myeloid antigen  (M1)  but lacked any T  cell antigens  (i.e., 
HNK+T3-MI+),  contained  abundant  cytoplasmic  granules,  and  exhibited  a  high 
level of NK activity. On the other hand, the minority (<40%) of blood HNK-1 + cells 
and almost all bone marrow HNK-1 + cells expressed the T  cell antigens (e.g., T3 and 
TS) but lacked the M1  antigen  (i.e.,  HNK+T3+M1-), had few cytoplasmic granules, 
and exhibited low NK function. 
In this study, we examined possible differentiation stages of HNK-1 + cells from all 
available lymphoid compartments (blood, spleen, lymph node, thymus, bone marrow, 
and fetal liver) to systematically characterize their phenotype, morphology, and NK 
cell function. The results of HNK-1 + cells examined from fetal to adult life indicated 
that there were at least three distinct stages of NK cell differentiation (HNK+T3-M 1-, 
HNK+T3+M 1-, and HNK+T3-M 1  +) and that they are selectively distributed among 
lymphoid tissues. 
Materials and Methods 
Cell Preparations.  Human  adult  spleen,  lymph  node,  and  thymus  were  obtained  from 
patients  undergoing  splenectomy for trauma,  diagnostic  lymph node  biopsies,  and  partial 
thymectomy to facilitate cardiac surgery,  respectively (6). Adult bone marrow was obtained 
from resected ribs in patients undergoing thoracic surgery. Single-cell suspensions were prepared 
as described  previously (7). 
* Supported by grants CA-13148,  CA-22197, CA-16673,  and RR 32  from the National Institutes of 
Health, and by the Medical Research Service of the Veteran's Administration. 
1 Abbreviations used in this paper: FACS, fluorescence-activated  cell sorter; FITC, fluorescein isothiocyanate; 
K, killer; NK, natural killer; RITC, tetramethylrhodamine isothiocyanate. 
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Human fetal tissue samples were obtained through the University of Alabama at Birmingham 
Tissue Procurement  Service from medically approved abortions. Single-cell suspensions were 
prepared from the fetal liver, bone marrow, spleen, and thymus within  1-2 h  after removal 
from the uterus. Erythrocytes were eliminated either by water-shock lysis or by Ficoll-Hypaque 
gradient centrifugation (3). Cord blood was obtained from neonates at full-term birth. Mono- 
nuclear cells from  both cord blood and  adult blood samples were separated by the Ficoll- 
Hypaque gradient centrifugation (3). All cell preparations were placed in RPMI 1640 medium 
supplemented with 10% heat-inactivated fetal calf serum plus 50 p,g/ml gentamycin. 
Immunofluorescence Assay.  Cell surface antigens defined by monoclonal antibodies were enu- 
merated by either direct or indirect two-color immunofluorescence assays (5).  A  monoclonal 
IgM  antibody,  HNK-1  (Leu-7;  Becton-Dickinson  &  Co.,  Sunnyvale,  CA)  was  used  at  a 
concentration of 10 ttg/ml for indirect immunofluorescence while fluorescein isothiocyanate 
(FITC)-  or tetramethylrhodamine isothiocyanate (RITC)-conjugated  HNK-1  antibody was 
used at a concentration of 50/ag/ml for the direct assay (5). For indirect two-color immunoflu- 
orescence, other monoclonal antibodies of IgG isotype were used in combination with the IgM 
HNK-1 antibody. A panel ofOKT monoclonal antibodies, T3, T8, T4, T6, Tg, T10, M1, and 
Ial (8-13), were obtained from Ortho Pharmaceutical, Raritan, NJ. A monoclonal anti-HLA- 
A,B,C common determinant antibody (PA 2.6)  was a  gift from Dr. A. J.  McMichael of the 
University of Oxford,  Oxford,  England  (14).  Secondary  antibodies were  FITC-  or  RITC- 
conjugated goat anti-mouse #, yl, "t'2a, and y2b heavy chain antibodies, which were generously 
provided by Dr. W. E. Gathings of the University of Alabama in Birmingham. 
Fluorescence-activated Cell Sorting.  Subpopulations of mononuclear cells after immunofluores- 
cence staining were analyzed and separated with a fluorescence-activated cell sorter (FACS IV; 
B-D FACS Systems, Becton-Dickinson & Co., Mountainview, CA) as described previously (5). 
NK Assay. NK cell function was examined by a 5~Cr-specific release assay using K562 target 
cells. The method and formula for calculating specific cytolysis have been described previously 
(3). The lytic units were calculated from the result of a dose-response curve of the effector cells. 
One lytic unit was defined as the number of effector cells required to achieve 30% lysis of 10  4 
target cells. 
Phagocytic Function and  Peroxidase Staining.  Phagocytic  functional  activity  was  tested  by 
phagocytosis of heat-killed yeast particles (15). Peroxidase staining was performed according to 
the technique of Kaplow (16). 
Results 
Fetal Expression  of liNK-1 and Other Differentiation  Antigens in Lymphoid Tissues.  The 
HNK-1  antigen was expressed on only a  small fraction (<0.2%)  of the nucleated cells 
recovered from the liver, bone marrow, and thymus (Table I) or from a  single spleen 
(data not shown)  from  13 to  17 wk-old fetuses. T  cell antigens, T3, T8, T4,  and T6 
were  identified on  <1%  of fetal  liver and  bone  marrow  cells, whereas  these T  cell 
antigens were found on most  fetal thymocytes (Table I). The majority (:>50%)  from 
cells from fetal liver and bone marrow expressed the myeloid antigen M1  (Table I). 
The  other  antigens T9,  T10,  HLA-DR  or  HLA-A,B,C were  also expressed  at  high 
levels of nucleated cells (20-40%). 
Co-expression of these antigens on fetal HNK-1 + cells from liver and bone marrow 
was  then  examined  with  a  two-color  immunofluorescence  assay  (Table  II).  The 
majority (>70%)  of HNK-1 + ceils lacked any of the other surface antigens tested. The 
remaining HNK-1 + cells (<30%)  co-expressed some mature T  cell antigens T3  and 
T8, but lacked T4, T6, and T9 antigens and lacked the myeloid antigen M 1. 
The fetal cells were then examined for surface and cytoplasmic expression of HNK- 
1 antigen. The HNK-1 + cells were sorted with the FACS after staining with FITC- T
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TABLE II 
Co-expression of Other Surface Antigens on HNK-1 + Cells in Lymphoid Tissues from Fetuses, Neonates, 
and Adults 
Tissues (number  Percem  HNK- I* cells explessing: 
tested) 
T3  T8  T4  T6  T9  TI0  MI  HLA-DR  HLA-A,B,C 
Fetuses (13-17 wk) 
Liver (2)  29 (21-37):[:  8  0  0  0  ND§  0  3  25 (22-28) 
Bone mat¢ow (6)  i8 (t3)  4  0  0  0  ND  0  5  20 (9) 
Neonates 
Blood (4)  77 (1 I)  51  (9)  19 (3)  0  0  ND  11 (3)  42 (7)  100 
Thymus II  (2)  80  82  >80  1.0  5  ND  0  NI)  >90 
Adults (15-40 yr) 
Bone marrow (4)  >95  86 (20)  18 (11)  0  0  ND  3  32 (14)  100 
Blood (6)  23 (20)  26 (7)  8 (3)  0  0  ~80  72 (18)  24 (7)  100 
Spleen (4)  64 (13)  25 (6)  6 (3)  0  0  ~50  35 (5)  41  (4)  I00 
Lymph node (2)  78 (74-82)  44 (42-46)  25 (21  29)  0  0  ND  I0 (7-I2)  5 (2-7)  100 
Thymus (2)  82 (77-86)  81  (79-82)  >90  <3.0  7  ND  0  ND  ND 
* An accurate enumeration  of T10 antigen expression was always difficult because  the staining intensity of this antibody  ranges from lov. to 
high degrees. 
2~ Nmnbers in parentheses indicate either the range of values for two observations or the SD for three or more observations, SD of le~s <:2% were 
not ~x:presented  to simplify the table. 
§ Not done. 
lJ Thymi¢ HNK-I + cells derived from both neonates and adults had a  minor bm specific phenotype.  Most of the cells expresged ~he helper ceil 
antigen (74) and few expressed  the T6 or T9 antigens 
HNK-1  antibody  and  then  restained  after  fixation  on  slides  with  RITC-HNK-1 
antibody.  Two  types of HNK-1 + cells  could  be  identified  in  fetal  liver  and  bone 
marrow. About 80% were relatively small (10-15/Lm), whereas a minority were quite 
large (>15/.tin)  (data not shown). None of these HNK-1 + cells  contained detectable 
cytoplasmic HNK- 1 antigen. 
Neonatal Expression  of liNK-1 and Other Differentiation  Antigens in Lymphoid Tissues and 
Cord Blood.  The proportion of  liNK-1 + cells was also very tow in neonates, comprising 
<1% of cord blood and bone marrow cells  (Table I). In contrast to fetal HNK-1 + cells 
that generally lacked other differentiation antigens, the majority (>80%) of HNK-1 + 
cells  in blood and thymus of neonates co-expressed the pan-T cell antigen  (T3)  and 
suppressor T  cell antigen (T8). About 18% blood HNK-1 + cells and 80% of HNK-I + 
thymocytes expressed a  helper T  cell antigen  (T4)  (Table II). In addition, almost all 
HNK-1 ÷ cells  expressed  HLA-A,B,C antigen,  whereas  42%  of blood  HNK-1 +  ex- 
pressed HLA-DR antigen. Very few neonatal HNK-1 + cells  expressed the immature 
T  antigen  (T6),  the  transferrin  receptor  (Tg),  or  the  myeloid  antigen  (M1).  The 
cytoplasmic expression of the HNK- 1 antigen in cord blood lymphocytes was weak. 
HNK-1  Antigen  Expression  in  Adults  Among  Lymphoid  Tissues.  The  proportion  of 
HNK-1 + cells was much higher in the blood and spleen of adults relative to neonates 
and fetuses  (Table I). This confirms our previous observation that  there is a  unique 
postnatal expansion of HNK-I + cells  (4). Moreover, the distribution of HNK-1 + cells 
is selective, being highest in adult blood (14%) and spleen (10%), but comprising <1% 
of nucleated cells in the lymph node, thymus, and bone marrow (Table I). 
We have previously described  two distinct  phenotypes of HNK-1 + cells  in  adult 
blood (5). The majority (>60%)  of HNK-1 + cells  were HNK+T3-M1 +, whereas the 
minority (<40%) were HNK+T3+M 1-. These reciprocal relationships were confirmed 
in this study and appeared to be valid in other tissues  as well.  Thus, the majority of T.  ABO,  C.  A.  MILLER, G.  L. GARTLAND, AND C.  M.  BALCH  277 
HNK-1 + cells from adult bone marrow, lymph node, and thymus co-expressed the T3 
and T8 antigens, but very few co-expressed M 1 antigen (Table II). Blood and spleen 
HNK-1 + cells, on the other hand, had the highest proportion of M 1 antigen expression 
and the lowest proportion of T  cell antigen expression (T3 and T8).  Only HNK-1 + 
cells from  the  adult  thymus  expressed  a  high  proportion  (>90%)  of helper  T  cell 
antigen  (T4) just as was observed in neonatal thymus  (>80%).  The immature T  cell 
antigen T6 and the transferrin receptor T9 were not expressed on HNK-1 + cells from 
adult, neonatal, or fetal lymphoid tissue. HLA-DR antigen expression on adult HNK- 
1  + cells was selectively distributed, being highest on splenic HNK-1 + cells (41%)  and 
lowest on HNK-1 + cells from lymph node  (5%). When the cytoplasmic expression of 
HNK-1  antigen  was  examined,  some  differences  were  observed  among  lymphoid 
compartments.  Adult  blood  HNK-1 +  cells  all  contained  a  diffuse  distribution  of 
HNK-1 antigen throughout the cytoplasm but not in the nucleus. HNK-1 + cells from 
bone  marrow  exhibited a  weaker stain  of cytoplasmic HNK-1  antigen  or lacked a 
detectable amount of antigen altogether. 
Distinguishing  Morphological Features of liNK-1 + Cells at Different  Stages of Differentia- 
tion.  As a  group, HNK-1 + cells from adult blood are a  homogeneous population of 
medium-sized  granular  lymphocytes  (3).  We  have  also  shown  that  they  can  be 
subdivided into two groups:  (a) HNK+T3-M1 + with abundant cytoplasmic granules 
that  are efficient cytotoxic cells and  comprise the  majority of blood HNK-1 + cells, 
and  (b)  HNK+T3+M1 -  cells with sparse granules that  have a  relatively low level of 
FIG.  1.  The morphological appearance of liNK-1  ÷ cells from adult blood, bone marrow, and fetal 
lymphoid tissues. FACS-sorted HNK-1 ÷ cells from adult blood (a), bone marrow (b), and fetal bone 
marrow (d, e, and f), including sorted HNK-I- cells from adult blood (c), were stained by May- 
Grfinwald-Giemsa method  (X  1,000). Three types of fetal HNK-1 + cells with distinct morphology 
are represented in d, e, and f. 278  STAGES  OF  NATURAL  KILLER  CELL  DIFFERENTIATION 
NK function  and comprise  a  minority  of blood  HNK-1 + cells  (5).  In  this  study,  we 
extended  these  observations  by examining  the morphology of FACS-purified  HNK- 
1  + cells  from other lymphoid  compartments  using the May-Griinwald-Giemsa  stain 
(Fig.  1).  Compared  with adult  blood  HNK-1 + cells  (Fig.  1 a), cord blood and  adult 
bone marrow  HNK-1 + cells  had fewer cytoplasmic  granules  (Fig.  1 b).  In  fact,  they 
are quite similar to the minor population  of adult blood HNK+T3+M 1- cells.  These 
cells  may represent  a  more immature  form of the HNK-1 + cells.  More than  98%  of 
the  HNK-1-  cells  sorted  by  the  FACS  from  the  above  sources  lacked  cytoplasmic 
granules  (Fig.  l c).  In  the  13-17-wk  fetuses,  three  distinct  morphological  types  of 
HNK-I +  cells  could  be  identified:  (a)  a  minor  population  (2-10%)  with  the  same 
granular appearance  as blood and bone marrow (Fig.  1 d),  (b) a  majority of HNK-1 + 
TABL~ III 
Demonstration of Spontaneous Killer Activity against K562 Using FACS-pur~'ed HNK-1 + Cells  from 
Fetal Bone Marrow 
Cell fraction  Target/effector 
ratio 
Percent 51Cr-specific release* 
13 wk fetus  16 wk fetus 
Unfractionated bone marrow cells:~ 
FACS-purified HNK- 1  + cells§ 
1:200  2.0  3.0 
l: 100  4.4  4.5 
1:50  3.9  3.5 
1:25  2.4  3.0 
1:12  2.9  3.1 
1:10  I1.1  15.3 
1:5  7.7  9.8 
1:2.5  5.0  6.0 
1:1.2  4.1  4.5 
1:0.6  2.5  3.0 
* In these studies, the killer activity was determined after an 18-h incubation to demonstrate the maximum 
activity. 
:~ By FACS analysis, the nucleated bone marrow cells in  13- and  16-wk fetuses were 0.06 and 0.1% HNK- 
1  +, respectively. However, these cells did not exhibit significant killer activity with a  clear dose-response 
correlation. 
§ FACS-purified  HNK-1 +  cells that  were >96%  pure  by  fluorescent  microscopy showed significant NK 
activity. 
BO 
©  60 
4O 
Q. 
~n 
~3 
2O 
Source of  Lyric  Units/ 
HNK-I + Cells  ]O T Ceils 
Adu(t 
Blood  700 
Cord  Blood  250 
AduJt  BM(I)  ~80 
Adult  BM(2)  170 
Fetal  BM (I)  80 
Fetal  BM (2)  40 
Control  HNK-I-  Cells 
~  -  -  -o----  ~  ~  ~  ~  from  Adult Blood  <  30 
1:06  I:12  12.5  1:5  I:10 
Target  to  Effector  CeH  Rotio 
FIG.  2.  A  comparison  of the  cytotoxic capabilities of FACS-purified  HNK-1 +  cells from  adult 
blood,  bone  marrow,  neonatal  cord  bh)od,  and  fetal  (15  and  17  wk)  bone  marrow.  Spontaneous 
killer activity against  K5623  target  cells were  measured  in  a  6-h  incubation  assay  using  FACS- 
purified  ItNK-1 +  cells. As a  control,  adult  blood  HNK-I-  cells, which  contained  less than  0.2',~ 
HNK-1 + by fluorescent microscopy, are shown in parallel. T.  ABO,  C.  A.  MILLER,  G.  L.  GARTLAND,  AND  C.  M.  BALCH  279 
cells  (70-80%)  that  were  small  to  medium  size  with  a  narrow  cytoplasm  and  no 
granules  (Fig.  1 e), and  (c)  a  small proportion  (15%)  of giant  HNK-1 + cells with  a 
large nucleus  and  a  broad  neutrophilic  cytoplasm  (Fig.  1 t'). These  latter  cells  are 
probably the same large cells noted in the fluorescence assay. All of these fetal HNK- 
1  + cells were negative for peroxidase staining and were incapable of phagocytosing 
yeast particles. 
NK Cell Functional Activity  in  the Fetus.  The spontaneous  killing  activity against 
K562  target  cells was  determined  for unfractionated  nucleated  bone marrow cells 
from  13-  and  16-wk fetuses  and  for FACS-purified  HNK-1 + cells  from those same 
bone marrows  (Table III). Although  unfractionated  whole  bone marrow cells con- 
tained  up  to 0.1%  HNK-1 + cells,  they did  not  exhibit  a  significant  killing activity 
with a dose-response correlation even at a  1:200 target/effector cell ratio. In contrast, 
purified  HNK-1 +  cells  from  both  of the  fetal  bone  marrows  exhibited  cytotoxic 
capability with a clear dose-response correlation. The NK activity of purified HNK- 
1  + cells was confirmed in another  13-wk fetus (data not shown)  and in two cases of 
15- and  17-wk fetuses (see Fig. 2). 
Comparison of  NK Cell Cytotoxicity  for Purified HNK- 1 + Cells From Different Sources.  The 
NK cell  functional  capability was compared in  FACS-purified  HNK-1 + cells from 
different sources. The objective was to correlate function  with surface antigen phe- 
notype. The maximal NK cell functional activity was in adult  blood HNK-1 + cells, 
the majority of which were HNK+T3-M1 + (Fig.  2).  HNK-1 + cells from cord blood 
and adult  bone marrow exhibited  a  reduced  functional  capability with about one- 
third the activity of adult blood HNK-1 + cells (Fig.  2).  Almost all of these HNK-I  + 
cells had the phenotype HNK+T3+M1 -. Minimal functional activity was observed in 
HNK-1 ÷ cells purified from fetal bone marrow and was <5% of that obtained with 
adult  blood.  The  majority  of  these  fetal  HNK-1 +  cells  had  a  phenotype  of 
HNK+T3-M1 -. 
Discussion 
These  results  demonstrated  an  excellent  correlation  of  NK  cell  function  with 
cellular morphology and  phenotypic antigen  expression,  because all  granular  lym- 
phocytes examined in adult, neonates, and fetal lymphoid tissues expressed the HNK- 
1 antigen  and because virtually all NK cell function resided in this cell population. 
The  validity of these  observations  is  strengthened  by similar correlations  in  other 
species,  as  granular  lymphocytes  in  mice  and  rats  are  known  to  possess  NK  cell 
function  (17-19). In humans, spontaneous cytotoxic function has been demonstrated 
using enriched populations of granular lymphocytes (20,  21).  Various combinations 
of cell surface markers have been demonstrated on these cytotoxic granular lympho- 
cytes as well as related fractions of cells (Ty and null ceils) (22-26). All of these surface 
markers, however, had overlapping representation on other functional subpopulations 
of lymphoid cells, thus making it difficult to purify the entire population of granular 
lymphocytes.  Only  the  HNK-1  differentiation  antigen  is  expressed  exclusively on 
granular lymphocytes (3). Functional characteristics of these FACS-purified cells have 
so far demonstrated  that  they possess both NK and K  cell functions  and that  they 
exhibit little or no proliferative response to mitogens (phytohemagglutinin, concana- 280  STAGES  OF  NATURAL  KILLER  CELL  DIFFERENTIATION 
valin A, and pokeweed mitogen) or to alloantigens  (27).  The cytotoxic efficiency of 
these HNK-1  + cells can be boosted with interferon (28). 
At least three subsets of HNK-1 + cells  were defined in this study having different 
surface  phenotypes:  HNK+T3-M1  -,  HNK+T3+M1  -,  and  HNK+T3-M1  +.  These 
three populations of HNK-1  + cells probably represent different stages of differentia- 
tion because they correlate well with distinct features of cellular morphology, cytotoxic 
functional capability, and distribution  in adult,  neonatal, and  fetal lymphoid com- 
partments.  A proposed model of HNK-1 + cellular differentiation is shown in Fig. 3. 
Recently, a  minor population of lymphocytes was  demonstrated to simultaneously 
express the T3 and M 1 antigens. These cells constitute 30% of the Ty cell fraction in 
blood, have low levels of NK function (26), and represent <5% of bone marrow HNK- 
1  ÷ cells  (5). These cells might represent a transitional stage of NK cells between that 
represented by the HNK+T3+M1  -  and HNK+T3-M1  + cells. 
The HNK+T3-M1- cells  represent the earliest definable stage of HNK-1 + cellular 
differentiation.  These  cells  were only identified  in  the  13-17  wk-old fetuses,  where 
they constituted  the  majority  (>70%)  of fetal  HNK-1 + cells.  These  early HNK-1 + 
cells comprised only a small proportion of nucleated ceils but they had several unique 
morphological features. About 15% of these cells were very large and lacked granules. 
The  majority of cells  (70-80%)  were  small  agranular  lymphocytes, whereas  only a 
small minority (~ 10%) were granular lymphocytes. Although these studies could not 
identify the maturational  stages of these cells,  it  is reasonable to speculate that  the 
agranular lymphocytes represent precursors of the granular lymphocytes. This possi- 
bility was supported by the finding that up to 20% of HNK-1 + cells  from the bone 
marrow of children and adults were small granular lymphocytes, but these cells were 
infrequent  (<5%)  in all other adult  lymphoid compartments (unpublished observa- 
tion). 
NK cell  function has not been previously demonstrated in the human fetus using 
unfractionated lymphoid cell populations (29). Even in this study, there was virtually 
no detectable NK activity using fetal bone marrow cells.  However, when the 0.1% of 
HNK-1 + bone marrow cells  was purified with the cell  sorter,  the purified  HNK-1 + 
cells exhibited a low level of NK function, thus confirming the functional correlations 
with  HNK-1  + ceils  and  NK function  in  adults.  It  is conceivable that  the  NK cell 
function  was  due  to  the  granular  HNK-I  +  fetal  cells,  but  there  were  insufficient 
numbers of cells to further separate granular and agranular HNK-1 + fetal cells. These 
data in humans are also supported by studies  in mice demonstrating the fetal  liver 
and bone marrow cells contain the precursors of NK cells  (30). 
The HNK+T3+M 1  -  cells probably represent an immature form of NK cells. These 
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cells have sparse cytoplasmic granules and relatively low levels of NK cell function 
(5). Only a small proportion (20-30%) of fetal HNK-1 + cells express the T3 antigen, 
but  the  vast  majority  (77-80%)  of neonatal  HNK-1 + cells are T3  +  (Table II).  In 
adults, this subset of cells comprised >95% of bone marrow, and -80% of HNK-1 + 
cells from the thymus and lymph nodes. Only a minority of blood HNK-1 ÷ cells had 
this immature phenotype. 
The most mature form of HNK-1 + cells have the HNK+T3-M 1  + phenotype. These 
cells have the highest level of NK cytotoxicity and the largest number of cytoplasmic 
granules (5). They were found predominately in adult blood and spleen. Their levels 
were  low  in  neonatal  blood  and  they  were  not  found  in  any  fetal  tissues.  The 
distribution  of these cells correlated precisely with  the  NK  cell  functional activity 
among these lymphoid compartments (e.g., high in adult blood, low in bone marrow 
or cord blood). NK cell activity in humans and in other species has been previously 
described as being the highest in blood and spleen, but lowest in thymus, lymph node, 
and tonsil (31). 
These studies of granular lymphocyte differentiation provided additional evidence 
that  human  NK cells may have a  unique lineage of differentiation, rather than a 
variant ofT cell or myeloid cellular differentiation. The HNK-1 antigen was expressed 
in the fetus without any co-expression of T  cell antigens on most cells; HNK-1 + cells 
lacked peroxidase activity, phagocytic activity, and did not express the DR and M 1 
antigens found on myeloid cells. The NK cell functional activity found in the purified 
population of fetal HNK-1 + bone marrow ceils at  13 wk gestation even precedes the 
acquisition  of cytotoxic function of T  cells  that  has  been  demonstrated  at  18 wk 
gestational age (32).  The granular HNK-1 + lymphocytes were quite low in number 
in all lymphoid compartments until childhood. They then expanded as a population 
through  adulthood,  a  period  when  the  thymus  gland  is  undergoing  involution. 
Although some HNK-1 + cells expressed mature T  cell differentiation antigens  (T3 
and T8), we did not detect an immature T  cell antigen  (T6) on these cells.  Finally, 
the  most  mature  subset  of HNK-1 +  granular  lymphocytes lacked  T  cell  antigens 
altogether. 
The differentiation schema proposed for granular HNK-I + lymphocytes is entirely 
compatible with the available data.  However, confirmation of this must be made by 
demonstrating that  these are sequential  stages  or by demonstrating a  switching of 
phenotypes in vitro with cultured HNK-1 + cells.  In this regard, we have established 
cultured  cell  lines  of  HNK-1 +  granular  lymphocytes,  all  of  which  have  the 
HNK+T3+M1 -  phenotype  (unpublished  data).  This  uniform  pattern  of antigen 
expression supports the proposed model of NK cell differentiation and may provide 
a  valuable tool for determining if these subsets of HNK-1 + cells can be induced to 
switch their rnaturational stage. 
Summary 
Virtually all  human  granular lymphocytes expressed the  HNK-1  differentiation 
antigen  when  examined  in  lymphoid  compartments  from  adults,  neonates,  and 
fetuses.  The  HNK-1 + cells  were  distinguishable  into  three subsets  having  distinct 
antigenic phenotypes:  HNK+T3-M1 -, HNK+T3+M1 -, and  HNK+T3-M1 +.  Thus, 282  STAGES  OF NATURAL KILLER CELL  DIFFERENTIATION 
>70% of the HNK-1 + cells from  13-17 wk fetuses (<0.2% of nucleated cells) lacked T 
cell antigens (e.g., T3, T8, T4, and T6) and the M 1 myeloid antigen. Morphologically, 
the HNK+T3-M  1- cells consisted of three different types: small granular lymphocytes 
(< 10% of HNK-1 + cells), agranular small lymphocytes with a narrow rim of cytoplasm 
(70-80%),  and agranular  giant cells (>15  ~m)  with  considerable neutrophilic cyto- 
plasm  (15%).  The  purified fetal HNK-1 ÷  cells exhibited a  low  level of cytotoxicity 
against K562 target cells. On the other hand, almost all of HNK-1 + cells in neonatal 
tissues  as  well  as  adult  bone  marrow,  lymph  node,  and  thymus,  exhibited  the 
HNK+T3+Ml-phenotype,  contained sparse cytoplasmic granules, and had an inter- 
mediate level of NK  functional  activity. Only adult blood and  spleen contained  a 
majority of mature  HNK-1 +  cells.  These  cells had  an  HNK+T3-M1 +  phenotype, 
abundant cytoplasmic granules, and maximum NK function. We propose that human 
NK cells may generate from a separate cell lineage and that they alter their phenotype," 
morphology, and functional capability during differentiation. 
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